Summary:
A randomized, double-blind, parallel-arm study comparing the efficacy of investigational product “Ibuprofen Modified-Release Tablets 800 mg” and placebo in patients with chronic pain related to osteoarthritis of the knee.
Qualified Participants Must:
• Male and female patients over the age of 18 and have been diagnosed with symptomatic OA of the knee. Participants cannot have a history of GI bleed and heart failure.
Qualified Participants May Receive:
$50 per visit (10 visits) and a total of up to $500 for the duration of the study.